-Reuters Citing NHK
B of A Securities Upgrades Elevance Health to Buy, Raises Price Target to $575
B of A Securities analyst Kevin Fischbeck upgrades Elevance Health (NYSE:ELV) from Neutral to Buy and raises the price target from $535 to $575.